Table 2.
Id. | Compounds | RT (min) | [M − H]− (m/z) | MS2 Ion Fragments (m/z) a | MS3 Ion Fragments (m/z) a | MS4 Ion Fragments (m/z) a | Location c |
---|---|---|---|---|---|---|---|
M1 | Hesperitin-O-glucuronide-sulfate | 3.32 | 557 | 381 b, 447 | 301 | 286, 242, 199, 283 | P |
M2 | Hesperitin-O-glucuronide-sulfate | 3.51 | 557 | 381, 447 | 301, 229 | 286, 242, 199, 283 | P, U |
M3 | Eriodictyol-O-glucuronide | 4.04 | 463 | 287, 175 | 151 | P, U | |
M4 | Naringenin-7-O-glucuronide | 4.09 | 447 | 271, 175 | 151, 177 | P, U | |
M5 | Naringenin-4′-O-glucuronide | 4.23 | 447 | 271, 175 | 151, 177 | P, U | |
M6 | Eriodictyol-O-glucuronide | 4.23 | 463 | 287, 175 | 151, 269 | P, U | |
M7 | Hesperitin-7-O-glucuronide | 4.45 | 477 | 301, 175 | 286, 243, 283 | P, U | |
M8 | Hesperitin-3′-O-glucuronide | 4.63 | 477 | 301, 175 | 286, 243, 283 | P, U | |
M9 | Naringenin-sulfate | 4.68 | 351 | 271 | 151, 177 | P | |
M10 | Eriodictyol-sulfate | 4.78 | 367 | 287 | 151 | P, U | |
M11 | Naringenin-sulfate | 4.82 | 351 | 271 | 151, 177, 165 | P | |
M12 | Hesperetin-sulfate | 4.9 | 381 | 301 | 286, 243, 283, 199 | P, U |
a Fragment ions are listed in order of relative abundance; b MS ions in bold were those subjected to successive MS fragmentation; c P, plasma; U, urine. RT, retention time.